Abstract
The cerebral protective actions of a new thyrotropin releasing hormone (TRH) analogue, YM-14673, [Na-[[(S)-4-oxo-2-azetidinyl-carbonyl]-L-histidyl-L-prolinamide] dihydrate), were compared with those of CDP-choline (cerebral metabolic enhancer) and naloxone in rats rats subjected to unilateral carotid artery ligation and anoxic exposure (Levine rats). Drugs were administered intraperitoneally or orally 20, 80, and 140 min after anoxia. YM-14673 (0.03 to 1 mg/kg i.p. and 0.3 to 10 mg/kg p.o.) decreased the incidence of neurological deficits, such as hemiplegia and convulsion followed by coma and death, for 48 h after ischemia and anoxia. Both the increase in the brain water content and the degeneration of neurons in the cerebral cortex and thalamus were prevented by YM-14673 at a dose of 0.1 mg/kg (i.p.). CDP-choline (400 mg/kg i.p.), which is currently used in the therapy of cerebral vascular diseases, and naloxone (3 mg/kg i.p.) also decreased the incidence of the neurological deficits. These results suggest that YM-14673 protects Levine rats against neurological deficits, presumably by attenuating the development of brain edema and preventing neuronal damage. This compound may be useful in the therapeutic treatment of cerebral...Continue Reading
References
May 1, 1979·Stroke; a Journal of Cerebral Circulation·W A Pulsinelli, J B Brierley
Jan 1, 1976·Stroke; a Journal of Cerebral Circulation·Y YamoriM Fukase
Mar 1, 1989·Stroke; a Journal of Cerebral Circulation·M YamamotoK Sano
May 8, 1989·Brain Research·A I Faden
Oct 1, 1989·Canadian Journal of Physiology and Pharmacology·C T O'ShaughnessyJ Shrewsbury-Gee
Aug 1, 1989·Stroke; a Journal of Cerebral Circulation·M YamamotoK Sano
Nov 1, 1987·Naunyn-Schmiedeberg's Archives of Pharmacology·M Yamamoto, M Shimizu
Jan 1, 1988·Experimental Brain Research·J Shrewsbury-GeeP Slater
Aug 8, 1981·Lancet·D S Baskin, Y Hosobuchi
Jan 1, 1982·Science·Y HosobuchiS K Woo
Oct 1, 1981·Annals of Neurology·A I FadenJ W Holaday
May 1, 1984·Stroke; a Journal of Cerebral Circulation·A I Faden
Nov 1, 1983·The International Journal of Neuroscience·M Yasuhara, H Naito
May 1, 1984·Stroke; a Journal of Cerebral Circulation·E F LundyL G D'Alecy
Jul 10, 1981·Science·J W HoladayA I Faden
Oct 29, 1981·The New England Journal of Medicine·A I FadenJ W Holaday
Sep 1, 1981·Regulatory Peptides·G MetcalfM E Havler
Oct 1, 1982·Neurology·A I FadenC Q Brown
Jul 26, 1982·Life Sciences·J W Holaday, R J D'Amato
Dec 13, 1982·Neuroscience Letters·C J Hannan, A R Garcia
May 1, 1982·Annals of Neurology·W A PulsinelliF Plum
Jan 30, 1981·Science·A I FadenJ W Holaday
Citations
Jan 1, 1996·Peptides·J E LarssonG Wahlström
Jan 1, 1997·Peptides·M Barbieri, A Nistri
Oct 13, 2001·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·K RejdakP Grieb
May 10, 2003·Neurobiology of Learning and Memory·N M W J De BruinL M Broersen
Nov 17, 2009·PloS One·Jean Lud CadetAmber B Hodges
Apr 26, 2011·Peptides·Satyendra Kumar RajputShyam Sunder Sharma
Apr 1, 1997·Journal of Pediatric Surgery·M D KleinA M Smith
Jan 2, 2004·The International Journal of Neuroscience·Süreyya Ataus AtausSevin Balkan
Oct 2, 1998·Stroke; a Journal of Cerebral Circulation·W ClarkK Hazel
Dec 3, 1999·Stroke; a Journal of Cerebral Circulation·W M ClarkR E Gammans
Feb 22, 2008·Acta neurochirurgica·A H MolnárF A László
Jan 6, 2015·Ayu·P Saravana PerumalS Krishan
Jul 13, 2000·Upsala Journal of Medical Sciences·L O KoskinenJ Svedberg
Jan 1, 1995·Life Sciences·G B Weiss